• COMPANY
    • LEADERSHIP
    • CAREERS
    • NIH GRANT SUPPORT
    • CONTACT US
  • TECHNOLOGY
  • APPLICATIONS
    • ALLOSTERIC TARGETS
    • SECONDARY SCREENING & MECHANISM OF ACTION
    • COMPLEX TARGETS
  • DRUG DISCOVERY SERVICES
    • Assay Development
    • Secondary Screening
    • TRUBIND AT WORK
      • PPI INTERACTIONS
      • TARGETING GPCRs
      • KINASE INTERACTIONS
  • PRODUCTS
  • LITERATURE
  • NEWS
  • EVENTS
    • On-Demand Presentations
    • Exhibitions
HOME APPLICATIONS

Applications

Back Scattering Interferometry (BSI) has broad application in life science research including small molecule drug discovery, biotherapeutic drug discovery, basic research, and mechanism of action studies.
Currently, MSI is focusing on drug discovery applications, specifically small molecule — complex target interaction characterization. MSI will publish data on additional applications in the near future, but in the meantime if you have specific research areas of interest that you would like to discuss, please contact us and we would be happy to review how BSI could support your efforts.

Learn more about BSI applications by clicking the links below:

ALLOSTERIC TARGETS

Direct binding quantification of low molecular weight ligands to ortho- and allosteric integral membrane protein and protein complex binding sites, under conditions where other technologies fail.

SECONDARY SCREENING

Direct binding confirmation of drug candidates from an HTS screen to the target of interest is critical to verification of a suspected MOA.

COMPLEX TARGETS

Complex drug targets for a large range of target classes have been successfully characterized in projects with major pharmaceutical companies.

Please send us an email or give us a call at (615) 938-7050 in North America or +49 (171) 760-4450 in Europe
to find out how MSI can help accelerate your assay development and screening efforts.

 

APPLICATIONS

  • ALLOSTERIC TARGETS
  • SECONDARY SCREENING & MECHANISM OF ACTION
  • COMPLEX TARGETS

SLAS2015 Exhibition & Tutorial

Visit our booth #1619 and attend our Tuesday Tutorial on Conformation-Sensitive Assay Detection for Accelerated Drug Discovery Research. Learn about the superior analytical power of TruBind™ Back Scattering Interferometry (BSI) technology for molecular interaction studies.
LEARN MORE>

TRY A LOW-RISK, HIGH-RETURN DRUG DISCOVERY PROJECT

Take advantage of our success-based drug-target characterization services including ortho- and allosteric membrane bound proteins, receptors, ion channels, protein complexes — your toughest targets.

LEARN MORE>

© Copyright 2015 by Molecular Sensing, Inc.
  • /Terms of Use
  • /Privacy Policy